INTRODUCTION Dementia, a syndrome characterized by a decline in cognitive function beyond what is expected from normal aging, poses a significant global health challenge. Alzheimer’s disease is the most common form of dementia, but other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. The impact of dementia extends far beyond the individual, placing a substantial burden on families, caregivers, and healthcare systems. Alongside the growing concern about dementia, depression is a prevalent mental health disorder affecting millions worldwide, particularly among older adults. Emerging research highlights a complex and bidirectional relationship between depression and dementia, suggesting that depression may not only be a risk factor for dementia but also a consequence of underlying neurodegenerative processes. Understanding this intricate relationship is crucial for developing effective prevention and intervention strategies. The present viewpoint aims to (1) summarize the epidemiological evidence linking depression to cognitive decline and dementia, (2) discuss mechanistic pathways that may underline this association, and (3) outline pragmatic, multilevel prevention strategies that can be implemented in clinical and public-health settings. EPIDEMIOLOGICAL EVIDENCE The complex relationship between depression and dementia has been a significant focus of research, revealing a compelling bidirectional link. Not only is comorbid depression highly prevalent among individuals with dementia, with studies reporting depressive symptoms in 37%–41% and major depressive disorder in approximately 16%, but evidence also strongly suggests that prior episodes of depression can increase the risk of developing dementia later in life.1,2 Meta-analyses have consistently shown a significant association between depression and an elevated risk of all-cause dementia.3-6 Further solidifying this connection, large-scale studies, including an exposure-wide association study involving hundreds of thousands of participants, indicate that a diagnosis of depression acts as a modifiable risk factor for future dementia.7 This is further corroborated by long-term follow-up studies emphasizing that individuals who experienced major depressive episodes in middle age face a higher risk of dementia in their elder years.8 These findings underscore the importance of proactively addressing depression not only for its immediate impact on well-being but also for its potential long-term implications for cognitive health.9 Interestingly, the use of antidepressants, while beneficial for treating depression itself, does not appear to offer protective benefits against the development of dementia or mild cognitive impairment (MCI).9 While antidepressants may not prevent dementia, specific classes of these medications may have cognitive benefits. Several studies suggest that antidepressants can have a modest positive effect on various cognitive functions, including attention, executive function, memory, and processing speed, particularly in depressed individuals.10 Selective serotonin reuptake inhibitors (SSRIs) seem to show the most significant positive impact on cognition in this population.11 Further, research has explored SSRIs for their effect on amyloid plaques. However, the association between antidepressant use and dementia risk remains nuanced.12 While some studies show certain types of antidepressants, like tricyclics, are associated with slightly higher dementia risk, others have found no overall association between antidepressant use and increased dementia risk, cognitive decline, or brain atrophy when compared with nonusage.13 There is a debate between some researchers over whether SSRIs hold any protective properties against the onset of dementia. This highlights the need for more research to clarify the potential role of specific antidepressant types in the complex interplay between depression and dementia. POTENTIAL MECHANISMS The link between depression and dementia is complex and multifaceted, involving a range of biological and lifestyle factors. One key mechanism centers on the hypothalamic–pituitary–adrenal (HPA) axis, which is often hyperactive in depressed individuals.14 This hyperactivity leads to elevated levels of glucocorticoids, particularly cortisol. Chronic exposure to high cortisol can damage vulnerable brain regions such as the amygdala, hippocampus, and prefrontal cortex,15 all of which are crucial for memory and cognitive function. Furthermore, glucocorticoids have been implicated in the progression of Alzheimer’s disease by promoting the production of amyloid-beta, hindering its breakdown, facilitating plaque formation, and exacerbating its toxic effects on neurons, as well as increasing tau accumulation.16 Beyond HPA axis dysregulation, depression is also associated with a state of chronic low-grade inflammation, characterized by elevated levels of inflammatory markers such as Interleukin-1 beta (IL-1 β), IL-6, tumor necrosis factor-alpha, and C-reactive protein.14 These inflammatory molecules can trigger damaging inflammatory pathways in the brain, leading to a reduction in brain-derived neurotrophic factor (BDNF).17 BDNF plays a critical role in neurogenesis, synaptic plasticity, and neuronal survival, and its reduction is seen in both depression and dementia.17,18 Finally, depression can contribute to an increased risk of cardiovascular disease, sleep disorders, smoking, and diabetes. These are established risk factors for dementia, suggesting that depression may indirectly increase the likelihood of developing dementia through these associated conditions. Thus, the association between depression and dementia is likely driven by a combination of neuroendocrine, inflammatory, and lifestyle factors, highlighting the need for a holistic approach to prevention and management. IMPLICATIONS FOR CLINICAL PRACTICE The link between depression and dementia has significant implications for clinical practice: Careful assessment and monitoring: Elderly patients presenting with memory impairment necessitate thorough assessment for both cognitive deficits and depressive symptoms. Depression can mimic cognitive impairment, and vice versa, making accurate diagnosis challenging. Regular monitoring for both conditions is crucial, particularly in individuals at high risk. As highlighted by Ronchetto and Ronchetto,19 depression is not just a risk factor; it can be a prodromal symptom Impact on neuropsychological assessments: Depression can significantly hinder neuropsychological assessments, making it difficult to accurately evaluate cognitive abilities. Depressed individuals may exhibit decreased motivation, concentration, and effort during testing, leading to an underestimation of their cognitive potential. Therefore, clinicians should consider addressing depression before concluding a diagnosis of dementia, postponing diagnosis until after treatment, as suggested by Ronchetto and Ronchetto19 Treatment strategies: Management of depression in older adults should encompass both pharmacological and nonpharmacological approaches. Nonpharmacological options, which have demonstrated efficacy in reducing depressive symptoms, should be considered alongside, or even in place of, pharmacological treatments, particularly for mild to moderate depression. These interventions, as substantiated by Farah et al.,20 can be crucial in managing depression in older adults Shared decision-making: When selecting between nonpharmacological therapies, a shared decision-making process that values patient preferences, clinical context, and social factors is crucial20 Pharmacological considerations: While pharmacological intervention may be necessary for moderate-to-severe depression, it is generally not first-line for mild-to-moderate depression in individuals with MCI, unless required for a preexisting severe mental health condition (Ronchetto and Ronchetto, 2022).19 For those requiring antidepressants, SSRIs may be considered, with referral to a mental health specialist necessary for nonresponders after at least 3 weeks of treatment.21 However, clinicians must be cautious about the potential cognitive side effects of certain medications, particularly anticholinergics and long-term use of SSRIs22-25 Optimizing treatment for depression: Optimizing treatment for depression can lead to improvements in depressive symptoms, quality of life, and physical functional status. Combining nonpharmacological approaches, especially those targeting cognitive function, such as physical activity and psychological interventions, with pharmacological strategies may offer added benefits. Moreover, antidementia cholinesterase inhibitors may positively impact depressive symptoms and synergistically enhance the effect of antidepressants.26 In cases of cognitive impairment, antidepressants with added cognitive-enhancing effects, such as duloxetine, venlafaxine/desvenlafaxine, tianeptine, vortioxetine, and mirtazapine, may be preferred26 Addressing behavioral risk factors: Behavioral risk factors common to both depression and dementia, such as obesity, sedentary lifestyles, sleep disorders, and excessive alcohol consumption, should be actively addressed. In addition, reducing social isolation and promoting positive social support are crucial to cognitive health and depression management in older people. The success of these interventions relies on adequate access to nonmedication therapies and strong support systems for both patients and their caregivers. Finally, more frequent screenings and consultations for individuals at high risk, along with strategies to reduce social isolation, may also be beneficial Figure 1. Figure 1: Implications for clinical practiceSTRATEGIES FOR PREVENTION Preventing both depression and cognitive decline requires a multifaceted approach that addresses modifiable risk factors and promotes overall well-being. Key strategies include: Promoting mental well-being: Encouraging social engagement, participation in meaningful activities, and stress management techniques can help prevent and manage depression. Cognitive behavioral therapy and other psychological interventions can be effective in reducing depressive symptoms and improving coping skills Encouraging physical activity: Regular physical activity has been shown to have numerous benefits for both mental and cognitive health. Exercise can improve mood, reduce stress, and enhance cognitive function. Aim for at least 150 min of moderate-intensity aerobic exercise per week, along with muscle-strengthening activities Maintaining a healthy diet: A balanced diet rich in fruits, vegetables, whole grains, and healthy fats is essential for brain health. The Mediterranean diet, in particular, has been associated with a reduced risk of cognitive decline and depression Managing chronic conditions: Controlling chronic conditions such as hypertension, diabetes, and cardiovascular disease is crucial for preventing vascular dementia and reducing the risk of depression Cognitive training: Engage in mentally stimulating activities, such as puzzles, reading, and learning new skills, to maintain cognitive function Sleep hygiene: Promoting good sleep hygiene, including maintaining a regular sleep schedule and creating a relaxing bedtime routine, can improve mood and cognitive function Social support: Encouraging older adults to participate in social activities, maintain relationships with family and friends, and volunteer in their communities can help prevent both depression and dementia Early detection and intervention: Implement routine screening for depression and cognitive impairment in older adults. Early detection allows for timely intervention and management, potentially slowing the progression of both conditions Addressing social determinants of health: Addressing social determinants of health, such as poverty, lack of access to healthcare, and inadequate housing, is essential for promoting mental and cognitive health in older adults. These factors can significantly impact an individual’s risk of developing both depression and dementia Education and awareness: Raising awareness among the public and healthcare professionals about the link between depression and dementia can promote early detection, timely intervention, and preventive strategies Support systems: Provide access to support groups, counseling services, and caregiver resources. Strong social support is crucial for both patients and their caregivers. RECOMMENDATIONS FOR FURTHER RESEARCH Investing in research to further elucidate the mechanisms underlying the depression-dementia link is crucial for the development of effective prevention and treatment strategies. To advance our understanding of this complex relationship, several areas of research warrant further investigation include: Investigating the cognitive benefits of specific antidepressant types: Further research is needed to determine which antidepressant medications are most effective in preventing or delaying cognitive decline Developing new therapeutic targets: The development of new therapeutic targets, such as anti-inflammatory medications or medications that target the HPA axis, may provide new avenues for the prevention and treatment of dementia Examining the role of lifestyle modifications: Further research is needed to determine the efficacy of lifestyle modifications, such as regular exercise and social engagement, in preventing or delaying cognitive decline Investigating the relationship between depression and dementia in diverse populations: Further research is needed to determine the relationship between depression and dementia in diverse populations, including minority groups and individuals with different socioeconomic backgrounds Digital and Remote Monitoring: Develop AI-driven mental health apps for real-time depressive symptom tracking and early dementia risk prediction using machine learning. CONCLUSION The association between depression and dementia is a significant public health concern, highlighting the importance of proactive management of depression for its immediate impact on well-being and its potential long-term implications for cognitive health. A multi-faceted prevention strategy encompassing early detection and treatment of depression, addressing behavioral risk factors, promoting social engagement and cognitive stimulation, and managing cardiovascular risk factors holds promise for reducing the burden of dementia in individuals with a history of depression. Further research is crucial to refine our understanding of this complex relationship and develop more effective prevention and treatment strategies. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Auda Fares (Thu,) studied this question.